UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Immunosuppression as a risk factor for COVID‐19: a meta‐analysis

Internal medicine journal, 2021-02, Vol.51 (2), p.199-205

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis

Internal medicine journal, 2024-03, Vol.54 (3), p.446-454

2024

Link zum Volltext

Verfügbarkeit prüfen

Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis

JGH open, 2020-06, Vol.4 (3), p.340-344

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: improving the use of Montreal classification through a bidirectional approach

Alimentary pharmacology & therapeutics, 2023-07, Vol.58 (1), p.112-113

2023

Link zum Volltext

Verfügbarkeit prüfen

Letter: tofacitinib in the real world – do clinical trial data stand up?

Alimentary pharmacology & therapeutics, 2023-03, Vol.57 (6), p.745-746

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of inflammatory bowel disease

Medical journal of Australia, 2018-10, Vol.209 (7), p.318-323

2018

Link zum Volltext

Verfügbarkeit prüfen

Letter: diagnostic delay in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2023-05, Vol.57 (10), p.1203-1204

2023

Link zum Volltext

Verfügbarkeit prüfen

Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis

ANZ journal of surgery, 2024-05, Vol.94 (5), p.795-803

2024

Link zum Volltext

Verfügbarkeit prüfen

NUDT15 genotype testing in inflammatory bowel disease patients in Australia

Internal medicine journal, 2022-11, Vol.52 (11), p.2016-2017

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service

Inflammatory bowel diseases, 2024-06, Vol.30 (6), p.960-969

2024

Link zum Volltext

Verfügbarkeit prüfen

Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal Fistulas

Clinical gastroenterology and hepatology, 2022-06, Vol.20 (6), p.1306-1314

2022

Link zum Volltext

Verfügbarkeit prüfen

Gastroduodenal Outlet Obstruction and Palliative Self-Expandable Metal Stenting: A Dual-Centre Experience

Journal of Oncology, 2013-01, Vol.2013, p.167851-6

2013

Link zum Volltext

Verfügbarkeit prüfen

Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity

Journal of gastroenterology and hepatology, 2015-09, Vol.30 (9), p.1346-1353

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single‐arm meta‐analysis

ANZ journal of surgery, 2023-05, Vol.93 (5), p.1162-1168

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessing aCCess to Investigations in Inflammatory Bowel Disease (ACCID): results from an international survey

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e837

2021

Link zum Volltext

Verfügbarkeit prüfen

ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease

Journal of Crohn's and colitis, 2023-07, Vol.17 (7), p.1031-1045

2023

Link zum Volltext

Verfügbarkeit prüfen

Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices

Liver international, 2016-02, Vol.36 (2), p.240-245

2016

Link zum Volltext

Verfügbarkeit prüfen

Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand

ANZ journal of surgery, 2024-02, Vol.94 (1-2), p.14-16

2024

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Journal of Crohn's and colitis, 2023-12, Vol.17 (12), p.1920-1930

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease

European journal of drug metabolism and pharmacokinetics, 2023-05, Vol.48 (3), p.271-279

2023

Link zum Volltext

Verfügbarkeit prüfen

Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial

The lancet. Gastroenterology & hepatology, 2022-04, Vol.7 (4), p.318-331

2022

Link zum Volltext

Verfügbarkeit prüfen

Su1805 Lipid Biomarker: Diagnostic Approach to Crohn's Disease Using Metabonomic Profiling in Serum and Faeces

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S557-S557

2016

Link zum Volltext

Verfügbarkeit prüfen

Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study

Scandinavian journal of gastroenterology, 2018-09, Vol.53 (9), p.1051-1058

2018

Link zum Volltext

Verfügbarkeit prüfen

186 Body Composition Profile: A Predictor of Therapeutic Outcome in Patients With Moderate to Severe Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S48-S49

2016

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study

Future pharmacology, 2022-12, Vol.2 (4), p.669-680

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Immunosuppression as a risk factor for COVID‐19: a meta‐analysis

Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis

Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis

Editorial: improving the use of Montreal classification through a bidirectional approach

Letter: tofacitinib in the real world – do clinical trial data stand up?

Management of inflammatory bowel disease

Letter: diagnostic delay in inflammatory bowel disease

Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis

NUDT15 genotype testing in inflammatory bowel disease patients in Australia

Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service

Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal Fistulas

Gastroduodenal Outlet Obstruction and Palliative Self-Expandable Metal Stenting: A Dual-Centre Experience

Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity

Autologous fat graft injections for the treatment of perianal fistulas in Crohn's disease: a systematic review and single‐arm meta‐analysis

Assessing aCCess to Investigations in Inflammatory Bowel Disease (ACCID): results from an international survey

ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease

Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices

Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand

Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease

Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial

Su1805 Lipid Biomarker: Diagnostic Approach to Crohn's Disease Using Metabonomic Profiling in Serum and Faeces

Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study

186 Body Composition Profile: A Predictor of Therapeutic Outcome in Patients With Moderate to Severe Crohn's Disease

Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study

Suchergebnisse filtern